caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1902820384

Philip SaylorM.D.

Hematology-OncologyBoston, MAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Philip Saylor's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 14 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
THE GENERAL HOSPITAL CORPORATION3593,931
Erika Meneely
Nurse Practitioner · Boston, MA
32110
Francis Mcgovern
Urology · Boston, MA
28182
Dushyant Sahani
Diagnostic Radiology · Seattle, WA
2680
Quest Diagnostics Massachusetts Llc
Clinical Laboratory · Marlborough, MA
1858
Chia-Sui Kao
Pathology · Stanford, CA
1844
PATTI, JOHN1538
Richard Sacknoff
Diagnostic Radiology · Boston, MA
1442
Gerald Abbott
Diagnostic Radiology · Boston, MA
1231
Yingbing Wang
Diagnostic Radiology · San Francisco, CA
1233
Florian Fintelmann
Diagnostic Radiology · Boston, MA
1126
DAWSON, STEVEN1127
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
783
Unique beneficiaries
—
Total services
1,148
Distinct HCPCS
7
Medicare payment
$85K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 360 Hematology-Oncology providers in MA — top quintile (cohort median 624).
PRESCRIBING · PART D · 2024
Total Rx claims
302
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
8
Brand share
28.1%
Top prescribed drugs
Darolutamide85 claims
Abiraterone Acetate65 claims
Prednisone43 claims
Bicalutamide28 claims
Alendronate Sodium26 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$57
Payment records
1
By payment type
Food and Beverage$57